BIO-KEY INTERNATIONAL INC (BKYI)
US09060C5076 - Common Stock
BKYI gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 277 industry peers in the Software industry. BKYI may be in some trouble as it scores bad on both profitability and health. BKYI is quite expensive at the moment. It does show a decent growth rate.
1. Profitability
1.1 Basic Checks
BKYI had negative earnings in the past year.
In the past year BKYI has reported a negative cash flow from operations.
BKYI had negative earnings in each of the past 5 years.
In the past 5 years BKYI always reported negative operating cash flow.
1.2 Ratios
The Return On Assets of BKYI (-93.73%) is worse than 90.15% of its industry peers.
The Return On Equity of BKYI (-275.70%) is worse than 85.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.73% | ||
| ROE | -275.7% | ||
| ROIC | N/A |
ROA(3y)-59.01%
ROA(5y)-166.67%
ROE(3y)-101.77%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
BKYI's Gross Margin of 66.27% is in line compared to the rest of the industry. BKYI outperforms 51.46% of its industry peers.
In the last couple of years the Gross Margin of BKYI has grown nicely.
The Profit Margin and Operating Margin are not available for BKYI so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.27% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5Y6.08%
2. Health
2.1 Basic Checks
BKYI does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for BKYI has been increased compared to 1 year ago.
BKYI has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BKYI has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -17.51, we must say that BKYI is in the distress zone and has some risk of bankruptcy.
With a Altman-Z score value of -17.51, BKYI is not doing good in the industry: 91.61% of the companies in the same industry are doing better.
A Debt/Equity ratio of 0.77 indicates that BKYI is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.77, BKYI is doing worse than 68.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -17.51 |
ROIC/WACCN/A
WACC8.18%
2.3 Liquidity
A Current Ratio of 1.30 indicates that BKYI should not have too much problems paying its short term obligations.
BKYI's Current ratio of 1.30 is on the low side compared to the rest of the industry. BKYI is outperformed by 62.41% of its industry peers.
A Quick Ratio of 0.59 indicates that BKYI may have some problems paying its short term obligations.
With a Quick ratio value of 0.59, BKYI is not doing good in the industry: 91.97% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.59 |
3. Growth
3.1 Past
BKYI shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1141.27%.
BKYI shows a strong growth in Revenue. In the last year, the Revenue has grown by 38.73%.
The Revenue has been growing slightly by 2.19% on average over the past years.
EPS 1Y (TTM)-1141.27%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-335.88%
Revenue 1Y (TTM)38.73%
Revenue growth 3Y45.69%
Revenue growth 5Y2.19%
Revenue growth Q2Q32.64%
3.2 Future
Based on estimates for the next years, BKYI will show a very strong growth in Earnings Per Share. The EPS will grow by 39.28% on average per year.
The Revenue is expected to grow by 64.75% on average over the next years. This is a very strong growth
EPS Next Y88.65%
EPS Next 2Y39.28%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year42.86%
Revenue Next 2Y64.75%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings Ratio is negative for BKYI. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for BKYI. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
A more expensive valuation may be justified as BKYI's earnings are expected to grow with 39.28% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.28%
EPS Next 3YN/A
5. Dividend
5.1 Amount
BKYI does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIO-KEY INTERNATIONAL INC
NASDAQ:BKYI (5/3/2024, 7:00:01 PM)
1.7
+0.01 (+0.59%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap3.08M
Analysts
Price Target
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | |||
| P/FCF | |||
| P/OCF | |||
| P/B | |||
| P/tB | |||
| EV/EBITDA |
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -93.73% | ||
| ROE | -275.7% | ||
| ROCE | |||
| ROIC | |||
| ROICexc | |||
| ROICexgc | |||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 66.27% | ||
| FCFM |
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.88
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.77 | ||
| Debt/FCF | |||
| Debt/EBITDA | |||
| Cap/Depr | |||
| Cap/Sales | |||
| Interest Coverage | |||
| Cash Conversion | |||
| Profit Quality | |||
| Current Ratio | 1.3 | ||
| Quick Ratio | 0.59 | ||
| Altman-Z |
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-1141.27%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y88.65%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)38.73%
Revenue growth 3Y45.69%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y